CD8A and cancer: CD8+T cells are key effector cells in the antitumor immune response, capable of promoting tumor growth by binding to T cell receptors on the surface of the tumor cells, by apoptosis mediated through granzymes and perforin, or by FASL-FAS-mediated cell death that disrupts target cell-specific recognition and kills cancer cells.